+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 0Days - 3Days
All Genders
Healthy Volunteers
ID07242508

A Randomized Controlled Trial Evaluating the Effects of a New Infant Formula with Bioactive Ingredients on Gut Bifidobacterium Levels in Healthy Infants

Led by FrieslandCampina · Updated on 2026-09-03

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the potential health benefits of a new infant formula composition in healthy infants up to 3 years old. The main goal is to determine whether this experimental formula increases the relative abundance of Bifidobacterium in stool samples after 10 weeks compared to a standard formula. Additionally, the study will monitor other markers of gut health including stool characteristics and gut health symptoms. Participants will be randomly assigned to receive either the experimental infant formula containing bioactive ingredients or a standard control formula. Both formulas will be consumed as the sole source of nutrition for the infant during the 10-week treatment period. The study is double-blind and placebo-controlled to ensure unbiased results. During the study, parents will follow study procedures including feeding the assigned formula exclusively. Researchers will collect stool samples to measure Bifidobacterium levels from enrollment through the end of the 10 weeks. Other gut health observations will also be recorded. The study is sponsored by FrieslandCampina and participation includes monitoring and assessments over the entire 10-week treatment period.

CONDITIONS

Brief Title

Efficacy of a New Infant Formula Composition on Gut Health in Infants

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here